Document Detail


Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
MedLine Citation:
PMID:  20385910     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare assessment of regional cerebral metabolic changes with [(11)C]dihydrotetrabenazine (DTBZ)-positron emission tomography (PET) measurement of regional cerebral blood flow (K(1)) and fludeoxyglucose F18 (FDG)-PET measurement of regional cerebral glucose uptake (CMR(glc)) in a clinically representative sample of subjects with mild dementia and mild cognitive impairment (MCI).
DESIGN: [(11)C]Dihydrotetrabenazine-PET K(1) and FDG-PET CMR(glc) measurements were performed.
SETTING: University-based cognitive disorders clinic.
PARTICIPANTS: Fifty subjects with either mild dementia (Mini-Mental State Examination score > or = 18) or MCI. Their results were compared with those of 80 normal control subjects.
MAIN OUTCOME MEASURES: The DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were compared with standard correlation analysis. The overall patterns of DTBZ-PET K(1) and FDG-PET CMR(glc) deficits were assessed with stereotaxic surface projections (SSPs) of parametric images.
RESULTS: The DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were highly correlated, both within and between subjects. The SSP maps of deficits in DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were markedly similar. The DTBZ-PET K(1) SSP maps exhibited a mild decrease in sensitivity relative to FDG-PET CMR(glc) maps.
CONCLUSIONS: Both DTBZ-PET K(1) and FDG-PET CMR(glc) measurements provide comparable information in assessment of regional cerebral metabolic deficits in mild dementia and MCI. Blood flow measures can assess regional cerebral metabolism deficits accurately in mild dementia and MCI. Blood flow assessments of regional cerebral metabolic deficits can be combined with tracer binding results to improve utility of PET imaging in mild dementia and MCI.
Authors:
Roger L Albin; Robert A Koeppe; James F Burke; Bruno Giordani; Michael R Kilbourn; Sid Gilman; Kirk A Frey
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Archives of neurology     Volume:  67     ISSN:  1538-3687     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-13     Completed Date:  2010-07-02     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  440-6     Citation Subset:  AIM; IM    
Affiliation:
VA Ann Arbor Health System Geriatrics Research, Education, and Clinical Center, and Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, USA. ralbin@umich.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age of Onset
Aged
Aged, 80 and over
Binding, Competitive / physiology
Brain Mapping / methods
Carbon Radioisotopes / diagnostic use
Cerebral Cortex / metabolism,  physiopathology,  radionuclide imaging*
Cerebrovascular Circulation / physiology
Cognition Disorders / metabolism,  physiopathology,  radionuclide imaging*
Dementia / metabolism,  physiopathology,  radionuclide imaging*
Early Diagnosis
Energy Metabolism / physiology
Female
Fluorodeoxyglucose F18 / diagnostic use*
Glucose / metabolism*
Humans
Image Processing, Computer-Assisted / methods
Male
Middle Aged
Positron-Emission Tomography / methods
Predictive Value of Tests
Radiopharmaceuticals / diagnostic use
Sensitivity and Specificity
Tetrabenazine / analogs & derivatives*,  diagnostic use
Grant Support
ID/Acronym/Agency:
AG08671/AG/NIA NIH HHS; NS15655/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Carbon Radioisotopes; 0/Radiopharmaceuticals; 3466-75-9/dihydrotetrabenazine; 50-99-7/Glucose; 58-46-8/Tetrabenazine; 63503-12-8/Fluorodeoxyglucose F18
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhag...
Next Document:  Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.